Basma G. Eid

2.2k total citations · 1 hit paper
66 papers, 1.3k citations indexed

About

Basma G. Eid is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Basma G. Eid has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Pathology and Forensic Medicine and 14 papers in Pharmacology. Recurrent topics in Basma G. Eid's work include Chemotherapy-induced organ toxicity mitigation (9 papers), Medicinal Plant Pharmacodynamics Research (7 papers) and Wound Healing and Treatments (5 papers). Basma G. Eid is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (9 papers), Medicinal Plant Pharmacodynamics Research (7 papers) and Wound Healing and Treatments (5 papers). Basma G. Eid collaborates with scholars based in Saudi Arabia, Egypt and United States. Basma G. Eid's co-authors include Nagla A. El‐Shitany, Ashraf B. Abdel‐Naim, Rasheed A. Shaik, Sabrin R. M. Ibrahim, Thikryat Neamatallah, Gamal A. Mohamed, Hamdy A.A. Aly, Hany M. El‐Bassossy, Alaa Sirwi and Shaimaa G. A. Mohamed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Basma G. Eid

62 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study

2021 167 citations Nagla A. El‐Shitany, Steve Harakeh et al. International Journal of General Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Basma G. Eid Saudi Arabia	21	404	196	176	174	146	66	1.3k
Nagla A. El‐Shitany Egypt	20	337 0.8×	139 0.7×	182 1.0×	199 1.1×	166 1.1×	51	1.5k
Soad Shaker Ali Saudi Arabia	19	207 0.5×	90 0.5×	172 1.0×	118 0.7×	104 0.7×	92	1.3k
Adam Szeląg Poland	24	462 1.1×	122 0.6×	62 0.4×	214 1.2×	173 1.2×	128	1.7k
Agnieszka Seremak‐Mrozikiewicz Poland	20	326 0.8×	113 0.6×	90 0.5×	88 0.5×	112 0.8×	169	1.5k
Taha Alqahtani Saudi Arabia	18	452 1.1×	90 0.5×	182 1.0×	91 0.5×	39 0.3×	87	1.6k
Yali Ren China	23	669 1.7×	135 0.7×	186 1.1×	82 0.5×	141 1.0×	70	2.1k
Dimitris Tsoukalas Greece	23	630 1.6×	80 0.4×	174 1.0×	69 0.4×	112 0.8×	49	2.0k
Hong Ye China	23	483 1.2×	131 0.7×	129 0.7×	42 0.2×	196 1.3×	108	2.0k
Marcelo Alarcón Chile	29	550 1.4×	143 0.7×	74 0.4×	78 0.4×	57 0.4×	69	1.9k
Khalaf F. Alsharif Saudi Arabia	22	417 1.0×	113 0.6×	104 0.6×	103 0.6×	96 0.7×	138	1.5k

Countries citing papers authored by Basma G. Eid

Since Specialization

Citations

This map shows the geographic impact of Basma G. Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basma G. Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basma G. Eid more than expected).

Fields of papers citing papers by Basma G. Eid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Basma G. Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basma G. Eid. The network helps show where Basma G. Eid may publish in the future.

Co-authorship network of co-authors of Basma G. Eid

This figure shows the co-authorship network connecting the top 25 collaborators of Basma G. Eid. A scholar is included among the top collaborators of Basma G. Eid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Basma G. Eid. Basma G. Eid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagher, Amina M., et al.. (2025). Piceatannol protects against cisplatin-induced ovarian toxicity in rats via modulation of PTEN/PI3 K/AKT axis. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(12). 17561–17571.

Abdel‐Naim, Ashraf B., et al.. (2025). Luteolin modulates the TGFB1/PI3K/PTEN axis in hormone-induced uterine leiomyomas: Insights from a rat model. European Journal of Pharmacology. 996. 177439–177439.

Shafiq, Sheikh, Shadab Md, Rasheed A. Shaik, et al.. (2023). Topical gel containing Polysiloxanes and hyaluronic acid for skin scar: Formulation design, characterization, and In vivo activity. Journal of Cosmetic Dermatology. 22(4). 1220–1232. 2 indexed citations

Md, Shadab, et al.. (2023). Protective effect of statistically designed and optimized Icariin nanoemulsion on doxorubicin-induced cardiotoxicity: Inhibition of oxidative stress, inflammation, and apoptosis. Journal of Drug Delivery Science and Technology. 81. 104297–104297. 5 indexed citations

Eid, Basma G., Thikryat Neamatallah, Amina M. Bagher, et al.. (2023). Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats. SHILAP Revista de lepidopterología. 23(6). 1069–1078.

Fule, Ritesh, Mohammed Kaleem, Turky Omar Asar, et al.. (2022). Formulation, Optimization and Evaluation of Cytarabine-Loaded Iron Oxide Nanoparticles: From In Vitro to In Vivo Evaluation of Anticancer Activity. Nanomaterials. 13(1). 175–175. 22 indexed citations

Alhakamy, Nabil A., Gamal A. Mohamed, Usama A. Fahmy, et al.. (2022). New Alpha-Amylase Inhibitory Metabolites from Pericarps of Garcinia mangostana. Life. 12(3). 384–384. 21 indexed citations

Eid, Basma G.. (2022). Chrysin attenuates estradiol-induced endometrial hyperplasia in rats via enhancing PPARα activity. Environmental Science and Pollution Research. 29(36). 54273–54281. 2 indexed citations

El‐Shitany, Nagla A., Amina M. Bagher, Basma G. Eid, et al.. (2022). The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study. International Journal of General Medicine. Volume 15. 6821–6836. 11 indexed citations

10.

Eid, Basma G., Nabil A. Alhakamy, Usama A. Fahmy, et al.. (2021). Melittin and diclofenac synergistically promote wound healing in a pathway involving TGF-β1. Pharmacological Research. 175. 105993–105993. 29 indexed citations

11.

Salam, Randa A. Abdel, Alaa El‐Gindy, Basma G. Eid, et al.. (2021). A green approach to the analysis of co-administered ampicillin/sulbactam and paracetamol in human urine. Acta Pharmaceutica. 72(2). 259–274. 1 indexed citations

12.

Ibrahim, Sabrin R. M., Alaa Sirwi, Basma G. Eid, Shaimaa G. A. Mohamed, & Gamal A. Mohamed. (2021). Fungal Depsides—Naturally Inspiring Molecules: Biosynthesis, Structural Characterization, and Biological Activities. Metabolites. 11(10). 683–683. 36 indexed citations

13.

Alhakamy, Nabil A., Sabna Kotta, Javed Ali, et al.. (2021). Formulation Development, Statistical Optimization, In Vitro and In Vivo Evaluation of Etoricoxib-Loaded Eucalyptus Oil-Based Nanoemulgel for Topical Delivery. Applied Sciences. 11(16). 7294–7294. 10 indexed citations

14.

Albadr, Nawal A., et al.. (2021). Icariin ameliorates metabolic syndrome-induced benign prostatic hyperplasia in rats. Environmental Science and Pollution Research. 29(14). 20370–20378. 12 indexed citations

15.

Neamatallah, Thikryat, Nagla A. El‐Shitany, Aymn T. Abbas, et al.. (2020). Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. Molecules. 25(13). 3031–3031. 13 indexed citations

16.

Alhakamy, Nabil A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, et al.. (2020). Piceatannol-Loaded Emulsomes Exhibit Enhanced Cytostatic and Apoptotic Activities in Colon Cancer Cells. Antioxidants. 9(5). 419–419. 34 indexed citations

17.

Alhakamy, Nabil A., Usama A. Fahmy, Osama A. A. Ahmed, et al.. (2020). Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity. Marine Drugs. 18(4). 226–226. 30 indexed citations

18.

Aly, Hamdy A.A. & Basma G. Eid. (2020). Cisplatin induced testicular damage through mitochondria mediated apoptosis, inflammation and oxidative stress in rats: impact of resveratrol. Endocrine Journal. 67(9). 969–980. 48 indexed citations

19.

Abdel‐Naim, Ashraf B., Mardi M. Algandaby, Fahad A. Al‐Abbasi, et al.. (2018). Rutin Isolated from Chrozophora tinctoria Enhances Bone Cell Proliferation and Ossification Markers. Oxidative Medicine and Cellular Longevity. 2018(1). 5106469–5106469. 38 indexed citations

20.

El‐Bassossy, Hany M. & Basma G. Eid. (2017). Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation. Biochemical and Biophysical Research Communications. 495(1). 468–472. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact